FDA Drug Approvals Top StoriesSee All
Thankfully, most thyroid cancers are treatable. However, when thyroid cancer comes back after treatment or spreads to other areas of the body, the disease is harder to treat.
Mantle cell lymphoma is a rare, but aggressive form of blood cancer. It’s a form of non-Hodgkin lymphoma. Patients with this disease got a new treatment option today.
New options developed this week for patients coping with two very different arthritic conditions. The US Food and Drug Administration (FDA) has approved two medications for treatment of both rheumatoid arthritis and ankylosing spondylitis.
For the first time in its history, the US Food and Drug Administration has approved a medication for the pre-surgical (neoadjuvant) treatment of early-stage (I, II) breast cancer.
Most thyroid cancers are treatable, even curable. However, as with most cancers, once spreading (metastasis) begins, tumors are more difficult to treat. A medication is being evaluated to strengthen the arsenal against advanced thyroid cancer.